These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 36439571)

  • 21. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
    Andrews N; Stowe J; Al-Shahi Salman R; Miller E
    Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome.
    Miller ER; McNeil MM; Moro PL; Duffy J; Su JR
    Vaccine; 2020 Nov; 38(47):7458-7463. PubMed ID: 33039207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.
    Vellozzi C; Iqbal S; Broder K
    Clin Infect Dis; 2014 Apr; 58(8):1149-55. PubMed ID: 24415636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination.
    Morehouse ZP; Paulus A; Jasti SA; Bing X
    Cureus; 2021 Sep; 13(9):e18153. PubMed ID: 34703690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent Guillain-Barre syndrome following vaccination.
    Baxter R; Lewis N; Bakshi N; Vellozzi C; Klein NP;
    Clin Infect Dis; 2012 Mar; 54(6):800-4. PubMed ID: 22267712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).
    Souayah N; Yacoub HA; Khan HM; Farhad K; Mehyar LS; Maybodi L; Menkes DL; Qureshi AI
    J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
    Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B;
    Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Oculopharyngeal Subtype of Guillain-Barré Syndrome Sparing the Trochlear and Abducens Nerves.
    Arakawa M; Yamazaki M; Toda Y; Ozawa A; Kimura K
    Intern Med; 2020 May; 59(9):1215-1217. PubMed ID: 32023583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.
    Razok A; Shams A; Almeer A; Zahid M
    Ann Med Surg (Lond); 2021 Jul; 67():102540. PubMed ID: 34249353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging infectious diseases, vaccines and Guillain-Barré syndrome.
    Koike H; Katsuno M
    Clin Exp Neuroimmunol; 2021 Aug; 12(3):165-170. PubMed ID: 34230841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan.
    Yen CC; Wei KC; Wang WH; Huang YT; Chang YC
    JAMA Netw Open; 2022 Sep; 5(9):e2232571. PubMed ID: 36129709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lighting Strikes Twice: Recurrent Guillain-Barré Syndrome (GBS) after Influenza Vaccination.
    Griffin G; Cunningham B; Beary JM; Spolter Y; Gandee R; Newey CR
    Case Rep Neurol Med; 2021; 2021():6690643. PubMed ID: 33614175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Characterization of CD4
    Voic H; de Vries RD; Sidney J; Rubiro P; Moore E; Phillips E; Mallal S; Schwan B; Weiskopf D; Sette A; Grifoni A
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
    Souayah N; Nasar A; Suri MF; Qureshi AI
    J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome following thoracic spinal cord trauma.
    Scozzafava J; Jickling G; Jhamandas JH; Jacka MJ
    Can J Anaesth; 2008 Jul; 55(7):441-6. PubMed ID: 18591702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré Syndrome with Respiratory Failure following Spine Surgery for Incomplete Cervical Cord Injury: A Case Report and Literature Review.
    Tu WC; Chang ST; Huang CH; Cheng YY; Hsu CS
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-varicella Guillain Barre syndrome.
    Hamad AI; Ghadban WK; Hamad AA; Al-Hail HJ
    Neurosciences (Riyadh); 2002 Oct; 7(4):299-300. PubMed ID: 23978865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.